Repaglinide (0.5mg) Voglibose (0.3mg)

Name: Repaglinide (0.5mg) Voglibose (0.3mg)
Brand: STERIS HEALTHCARE PRIVATE LIMITED
Price: 55.00 INR
Availability: InStock

Price 55.00 INR/ Piece

Get a Price/Quote

MOQ : 1 Piece

Repaglinide (0.5mg) Voglibose (0.3mg) Specification

Origin of Medicine
India

Ingredients
Repaglinide (0.5mg), Voglibose (0.3mg)

Physical Form
Tablets

Dosage
As per suggestion

Dosage Guidelines
As per suggestion

Suitable For
Adults

Quantity
5000 Boxes

Storage Instructions
Cool & dry place

Repaglinide (0.5mg) Voglibose (0.3mg) Trade Information

Minimum Order Quantity
1 Piece

Supply Ability
5000 Pieces Per Day

Delivery Time
5 Days

Sample Policy
Contact us for information regarding our sample policy

Main Domestic Market
All India

Certifications
WHO, GMP & ISO Certified

About Repaglinide (0.5mg) Voglibose (0.3mg)

Repaglinide and Voglibose
Rapiglinide VOG are both medications used to treat type 2 diabetes mellitus, but they work in different ways.
Repaglinide is an oral hypoglycemic medication that belongs to the class of drugs known as meglitinides. Rapiglinide VOG works by stimulating the release of insulin from the pancreas, Rapiglinide VOG helps to lower blood sugar levels after a meal. Rapiglinide VOG is taken before meals to help control postprandial (after meal) glucose spikes.
Voglibose is an alpha-glucosidase inhibitor that works by slowing down the breakdown and absorption of carbohydrates in the small intestine, leading to a slower and more gradual increase in blood sugar levels after a meal. Voglibose is taken Rapiglinide VOG meals to help control postprandial hyperglycemia.
Both medications can be used alone or in combination with other medications, such as metformin, to help control blood sugar levels in people with type 2 diabetes. Rapiglinide VOG with all medications, Rapiglinide VOG is important to follow your healthcare provider's instructions for use and to discuss any potential side effects or interactions with other medications.
Rapiglinide VOG is available in strengths of 1.0 & 0.5 mg
For further information please contact:
contact@sterispharma.com

Advanced Dual-Action Control

This medication combines Repaglinide and Voglibose to target postprandial (after meal) blood sugar levels in adults with type 2 diabetes. Both ingredients work together to enhance glycemic control through complementary mechanisms, ensuring stability and reducing the risk of complications.

Reliable Indian Origin and Quality

Produced in India, these tablets adhere to robust pharmaceutical standards. With 5000 boxes available, supply is reliable for bulk requirements. Each tablet contains precisely measured doses, supporting consistent treatment practices for healthcare providers and patients.

Proper Storage and Handling Guidance

To preserve the potency and safety of Repaglinide (0.5mg) and Voglibose (0.3mg) Tablets, always store them in a cool and dry location. Avoid humidity and direct sunlight, adhering to these guidelines to maintain shelf life and effectiveness.

FAQ's of Repaglinide (0.5mg) Voglibose (0.3mg):

Q: How should Repaglinide (0.5mg) and Voglibose (0.3mg) Tablets be stored?

A: These tablets should be kept in a cool and dry place, protected from direct sunlight and moisture. Proper storage ensures the medication maintains its efficacy throughout its shelf life.

Q: What is the recommended dosage for this combination tablet?

A: The dosage should be determined and prescribed by a qualified healthcare professional, based on individual patient needs and medical advice. Self-medication is not recommended.

Q: When are these tablets typically taken during diabetes management?

A: Repaglinide and Voglibose tablets are usually taken before or with meals to help control blood sugar spikes that occur after eating. Timing and frequency should be as per your doctor's guidelines.

Q: Who is suitable to use Repaglinide and Voglibose tablets?

A: These tablets are suitable for adults diagnosed with type 2 diabetes and are to be used following the guidance of a medical expert. They are not intended for children or those with type 1 diabetes.

Q: What are the main benefits of using this medication combination?

A: This dual-action medication helps improve glycemic control by reducing post-meal blood sugar surges, thereby aiding in diabetes management and reducing related complications.

Q: Where is this medication sourced and supplied from?

A: These tablets are manufactured and supplied in India, ensuring reliable availability for traders and healthcare institutions requiring bulk quantities.

Q: What is the process for obtaining this product in bulk?

A: To purchase Repaglinide (0.5mg) and Voglibose (0.3mg) Tablets in large volumes, contact the supplier or trader in India, specifying the number of boxes (5,000 available) and meeting any necessary regulatory requirements.

Tell us about your requirement